Rapid learning curve to TTVR with the Cardiovalve device

Explore the discussion between Rodrigo Estevez Loureiro and Georg Nickenig on treating tricuspid regurgitation with the innovative Cardiovalve replacement therapy. Learn about the unique features and properties of this low-profile valve with a dual frame, and hear Estevez Loureiro share his firsthand experience using the TTVR device on patients, including significant reductions in tricuspid regurgitation and positive outcomes in right ventricular remodeling, supporting the safety profile of the device. These promising results align with those of the ongoing TARGET Trial.

This interview was filmed at EuroPCR 2024: see more videos here.